Legal & General Group PLC Travere Therapeutics, Inc. Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

A detailed history of Legal & General Group PLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 90,972 shares of TVTX stock, worth $1.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
90,972
Previous 90,972 -0.0%
Holding current value
$1.57 Million
Previous $1.27 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$7.89 - $15.21 $102,538 - $197,669
12,996 Added 16.67%
90,972 $1.27 Million
Q2 2024

Aug 14, 2024
BUY
$5.26 - $8.28 $14,848 - $23,374
2,823 Added 3.76%
77,976 $640,000
Q1 2024

May 14, 2024
SELL
$7.18 - $9.82 $428,638 - $586,244
-59,699 Reduced 44.27%
75,153 $579,000
Q4 2023

Feb 15, 2024
SELL
$5.44 - $9.5 $201,769 - $352,355
-37,090 Reduced 21.57%
134,852 $1.21 Million
Q3 2023

Nov 14, 2023
BUY
$7.64 - $17.25 $278,126 - $627,969
36,404 Added 26.86%
171,942 $1.54 Million
Q2 2023

Aug 14, 2023
BUY
$15.3 - $22.61 $157,681 - $233,018
10,306 Added 8.23%
135,538 $2.08 Million
Q1 2023

May 15, 2023
BUY
$17.82 - $22.89 $889,912 - $1.14 Million
49,939 Added 66.33%
125,232 $2.82 Million
Q4 2022

Feb 14, 2023
BUY
$18.47 - $26.14 $207,067 - $293,055
11,211 Added 17.49%
75,293 $1.58 Million
Q3 2022

Nov 14, 2022
BUY
$22.91 - $28.63 $950,329 - $1.19 Million
41,481 Added 183.54%
64,082 $1.58 Million
Q2 2022

Aug 22, 2022
BUY
$20.94 - $30.01 $20,039 - $28,719
957 Added 4.42%
22,601 $548,000
Q1 2022

May 16, 2022
BUY
$23.61 - $30.6 $7,035 - $9,118
298 Added 1.4%
21,644 $558,000
Q4 2021

Feb 14, 2022
BUY
$24.34 - $31.17 $2,628 - $3,366
108 Added 0.51%
21,346 $663,000
Q3 2021

Nov 15, 2021
BUY
$12.98 - $25.03 $140,391 - $270,724
10,816 Added 103.78%
21,238 $515,000
Q2 2021

Aug 12, 2021
SELL
$14.11 - $26.4 $16,805 - $31,442
-1,191 Reduced 10.26%
10,422 $152,000
Q1 2021

May 17, 2021
BUY
$23.37 - $31.77 $40,149 - $54,580
1,718 Added 17.36%
11,613 $290,000
Q4 2020

Feb 12, 2021
BUY
$19.17 - $27.87 $189,687 - $275,773
9,895 New
9,895 $270,000

Others Institutions Holding TVTX

# of Institutions
193
Shares Held
84.6M
Call Options Held
776K
Put Options Held
900K
View Full List

About Travere Therapeutics, Inc.

TVTX Quotes by TradingView
  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.11B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email